Skip to main content
. 2019 May 24;14:3743–3752. doi: 10.2147/IJN.S193258

Figure 2.

Figure 2

Cell viability of NIR-Alb NPs in U87 (A), U251 (B), U373 (C), and LN229 (D) cell lines. The NPs were treated at a concentration of 10, 30, 50, 100, and 500 µg/mL lines for 24, 48, and 72 hrs.

Abbreviation: NIR-Alb NPs, near-infrared dye-incorporated albumin nanoparticles.

HHS Vulnerability Disclosure